Lee Myungmi, Rhee Inmoo
Department of Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea.
Immune Netw. 2017 Aug;17(4):214-227. doi: 10.4110/in.2017.17.4.214. Epub 2017 Aug 9.
Cytokines are molecules that play critical roles in the regulation of a wide range of normal functions leading to cellular proliferation, differentiation and survival, as well as in specialized cellular functions enabling host resistance to pathogens. Cytokines released in response to infection, inflammation or immunity can also inhibit cancer development and progression. The predominant intracellular signaling pathway triggered by cytokines is the JAK-signal transducer and activator of transcription (STAT) pathway. Knockout mice and clinical human studies have provided evidence that JAK-STAT proteins regulate the immune system, and maintain immune tolerance and tumor surveillance. Moreover, aberrant activation of the JAK-STAT pathways plays an undeniable pathogenic role in several types of human cancers. Thus, in combination, these observations indicate that the JAK-STAT proteins are promising targets for cancer therapy in humans. The data supporting this view are reviewed herein.
细胞因子是一类分子,在多种正常功能的调节中发挥关键作用,这些功能包括导致细胞增殖、分化和存活,以及在使宿主抵抗病原体的特殊细胞功能中发挥作用。响应感染、炎症或免疫而释放的细胞因子也可抑制癌症的发生和进展。细胞因子触发的主要细胞内信号通路是JAK-信号转导子和转录激活子(STAT)通路。基因敲除小鼠和临床人体研究已提供证据表明,JAK-STAT蛋白调节免疫系统,并维持免疫耐受和肿瘤监测。此外,JAK-STAT通路的异常激活在几种人类癌症中起着不可否认的致病作用。因此,综合这些观察结果表明,JAK-STAT蛋白是人类癌症治疗的有前景的靶点。本文综述了支持这一观点的数据。